Hôpitaux Universitaires Henri-Mondor

What Hôpitaux Universitaires Henri-Mondor does

Hôpitaux Universitaires Henri-Mondor is a French public university hospital group (GHU) operating as part of Assistance Publique-Hôpitaux de Paris (AP-HP), the largest university hospital system in Europe. The group comprises five hospitals — Henri-Mondor, Albert-Chenevier, Emile-Roux, Dupuytren, and Georges-Clemenceau — distributed across the Val-de-Marne (94) and Essonne (91) departments in the eastern Paris region, with a Créteil-based headquarters and 2,352 hospital beds. It employs approximately 9,200 healthcare professionals, including 5,595 nurses, and operates across 58 medical specialties organized into eight Medical University Departments (DMUs), delivering emergency, inpatient, outpatient, interventional, rehabilitation, psychiatric, and geriatric services to the general population. The institution is academically affiliated with Université Paris-Est Créteil (UPEC) and hosts INSERM's Institut Mondor de Recherche Biomédicale (IMRB), the Vaccine Research Institute (VRI), and 904 active research projects including eight rare disease reference centers under the ESMARA platform.

The group's core technology footprint centers on the newly inaugurated Centre Interventionnel et Ambulatoire (CIA) — a €36 million interventional and ambulatory facility opened in July 2026 with 14 dedicated interventional rooms spanning interventional cardiology, neuroradiology, onco-vascular radiology, and digestive endoscopy, supported by 21 operating block rooms, 45 post-interventional surveillance beds, and a 40-place day hospital. Additional advanced technology assets include Da Vinci second-generation robotic surgical systems, a 3 Tesla MRI for the Fonction-Image-Thérapeutique pole, multi-energy Angio-CT imaging, AI-enabled diagnostic tools for radiology and digital pathology, and the AP-HP Health Data Warehouse (EDS) used for clinical research and feasibility studies. The hospital runs a clinical trials registry containing over 56,000 trials associated with the institution.

Henri-Mondor is funded through the French national health insurance system (Sécurité sociale) under the T2A (tarification à l'activité) diagnosis-related group reimbursement model, with revenue being effectively derived from public healthcare tariffs rather than commercial transactions. Patient access occurs via the Doctolib online appointment platform, direct admissions, healthcare professional referrals, the 24/7 emergency department (SAU), and home hospitalization (HAD). The group's value proposition combines care delivery, biomedical research, and medical education, with a particular focus on oncology through the Institut Universitaire du Cancer Henri-Mondor, rare disease management via ESMARA, and supportive oncology care through the CALIPSSO platform. Distribution extends across multiple digital and physical channels including the official website, MON AP-HP patient portal, social media presence (Facebook, Instagram, YouTube, Bluesky), and the monthly newsletter "30 jours à Mondor."

Name

Hôpitaux Universitaires Henri-Mondor

Legal name

Assistance Publique-Hôpitaux de Paris

Website

https://chu-mondor.aphp.fr

Company type

Public

Founded year

1969

Operating status

Operating

Headcount range

51–100 employees

Short description

Public French university hospital group under AP-HP, operating five hospitals across Val-de-Marne and Essonne with 9,200 staff and 2,352 beds, delivering comprehensive care, research, and medical education across 58 specialties to the eastern Paris population.

Ownership category

akta.pro rank

Product category

Public University Hospital Services

NAICS

General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110), Offices of Physicians (6211), Offices of Physicians (62111)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060), Services-Health Services (8000), Services-Home Health Care Services (8082)

akta.pro primary industry

Cardiac & Cardiothoracic Specialty Hospitals (HLAFAHAA)

Keywords

• Public hospital services
• University hospital care
• Interventional cardiology
• Oncology treatment
• Clinical research trials

Headquarters

HQ city

Créteil

HQ country

France

HQ region

Europe

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Others

Revenue model

1. Public Healthcare Services: As a French public university hospital (établissement public de santé), Henri-Mondor generates revenue through the French national health insurance system (Sécurité sociale). Services are reimbursed based on diagnosis-related groups (T2A - tarification à l'activité) and include consultations, hospitalizations, surgical procedures, emergency care, and medical procedures.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Hôpitaux Universitaires Henri-Mondor operates a public university hospital group providing comprehensive medical care across emergency services, interventional procedures, oncology, rare diseases, rehabilitation, psychiatry, and geriatric care. The group combines clinical service delivery with biomedical research and medical education, supported by advanced technologies including robotic surgery, AI-enabled diagnostics, and a dedicated interventional center, while offering access to clinical trials and innovative treatments.

Product overview

Hôpitaux Universitaires Henri-Mondor operates as a university hospital group (GHU) comprising five hospitals: Henri-Mondor, Albert-Chenevier, Emile-Roux, Dupuytren, and Georges-Clemenceau. The hospital group offers comprehensive medical services including the Centre Interventionnel et Ambulatoire (CIA) for interventional procedures, the Institut Universitaire du Cancer (IUC) for cancer care, emergency services, rare disease expertise (ESMARA), clinical investigation, rehabilitation, psychiatry, and palliative care. Digital services include online appointment booking and a clinical trials registry with over 56,000 trials. The group features 8 reference centers for rare diseases and supports approximately 904 ongoing research projects.

Differentiator

Problem solved

Functional benefit

Products and services

• Centre Interventionnel et Ambulatoire (CIA) A state-of-the-art interventional and ambulatory center offering cardiology, neuroradiology, onco-vascular interventional radiology, and digestive endoscopy services for patients requiring minimally invasive procedures, with integrated day hospital capacity.
• Institut Universitaire du Cancer Henri-Mondor (IUC)

Quantifiable outcome

• 30%+ increase in interventional procedures
• +2 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature6 records

Partnerships

16 partnerships are on record, tiered core, major and minor.

• Université Paris-Est Créteil (UPEC)coreStrategic or Co-development Partner · 1 January 2024Academic partnership with UPEC medical faculty for medical education, training, and research. Medical students train at the hospital, and research collaborations advance medical knowledge.
• ESMARA - Plateforme d'Expertise Maladies Rares Grand Paris EstcoreStrategic or Co-development PartnerRare disease expertise platform coordinating care for patients with rare diseases across multiple reference and competence centers.
• Institut Mondor de recherche biomédicale (IMRB)coreStrategic or Co-development PartnerINSERM research institute located on the Mondor campus conducting biomedical research across multiple departments.
• Fondation FondamentalcoreStrategic or Co-development PartnerResearch foundation focused on psychiatric disorders and neuroscience, conducting research at the Mondor campus.
• ANRS / France Recherche Nord & Sud SIDA-HIV HépatitescoreStrategic or Co-development PartnerPublic research organization coordinating and funding research on HIV/AIDS and viral hepatitis. ANRS is a key partner of the Vaccine Research Institute (VRI) at Mondor.
• Vaccine Research Institute (VRI)coreStrategic or Co-development PartnerVaccine research institute labeled in 2011 under the Labex program. Led by Pr Yves Levy, the VRI conducts HIV and hepatitis C vaccine research, including 3 ongoing HIV vaccination trials.
• Centre Hospitalier Intercommunal de Créteil (CHIC)majorStrategic or Co-development PartnerCollaborative partnership with neighboring public hospital for healthcare coordination in the Créteil area.
• Centre Hospitalier Intercommunal de Villeneuve Saint-Georges (CHIV)majorStrategic or Co-development PartnerHealthcare collaboration with the Villeneuve Saint-Georges hospital for regional care coordination.
• Centre Hospitalier du Sud Francilien (CHSF)majorStrategic or Co-development PartnerPartnership with the Sud Francilien hospital center in Evry-Corbeil for regional healthcare cooperation.
• Réseau Roc Est 94minorStrategic or Co-development PartnerCancer care network coordinating quality cancer care for patients in eastern Paris region, providing psychological support, nutritional counseling, and socio-esthetic services.
• SINDEFI-SEPminorStrategic or Co-development PartnerMultiple sclerosis and inflammatory nervous system diseases network connecting neurologists and healthcare professionals across Ile-de-France.
• DoctolibcoreTechnology or IntegrationOnline appointment booking platform integrated with hospital services for patient convenience.
• ColoplastminorOthersMedical device company partner participating in cancer awareness events and patient education.
• AstraZenecaminorOthersPharmaceutical company partner in cancer awareness initiatives and patient support programs.
• AstellasminorOthersPharmaceutical partner in bladder cancer awareness day activities and patient education.
• MSDminorOthersHealthcare company partner in cancer awareness and patient information programs.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Hôpitaux Universitaires de Genève (HUG): Large public university hospital group across the Lake Geneva region with a comparable care-research-teaching mandate, multi-site structure, and similar specialty breadth; comparable in operational model though in a different jurisdiction.
• Erasmus MC: Dutch university medical center combining patient care, research, and education with a similar specialty breadth and academic affiliation model; comparable as a European academic tertiary provider, though operating under Dutch regulated competition.
• King's College Hospital NHS Foundation Trust: Major UK academic tertiary center with strong interventional, oncology, and research portfolios; comparable in scale, multi-site governance, and academic medical partnerships, though funded via the NHS rather than French social insurance.
• Charité – Universitätsmedizin Berlin: One of Europe's largest university hospitals with four campuses and an integrated research-and-teaching mission analogous to Henri-Mondor's; operates under a different reimbursement system but with comparable scale and academic depth.

Direct peers

• Hôpitaux Universitaires de Strasbourg: University hospital group with similar blend of general acute, interventional, oncology, and research services, operating under the same French public-hospital regulatory and reimbursement framework.
• Hospices Civils de Lyon: France's second-largest university hospital group with 14 hospitals and a similar care-research-teaching triple mission. Comparable in scale, specialty breadth, and academic affiliation model to Henri-Mondor's GHU structure.
• Assistance Publique – Hôpitaux de Marseille (AP-HM): Another major French university hospital group serving the Provence region with multi-site hospitals and similar AP-style governance, academic partnerships, and T2A-funded economics.
• Gustave Roussy: Leading European cancer center affiliated with AP-HP/Universtié Paris-Saclay and a direct oncology peer to Henri-Mondor's Institut Universitaire du Cancer; competes for the same complex oncology and clinical-trial referrals in Île-de-France.
• CHU de Bordeaux: Major French university hospital with comparable multi-site structure, advanced interventional platforms, and strong oncology and rare-disease expertise, serving the Nouvelle-Aquitaine region.

Broad incumbents

• Assistance Publique – Hôpitaux de Paris (AP-HP): Parent organization and largest university hospital system in Europe (38 hospitals). Henri-Mondor is one of its GHU groups, so AP-HP is the direct umbrella incumbent it operates within and benchmarks against.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ghumondor
• YouTubeyoutube.com/@groupehenrimondor/videos
• Facebookfacebook.com/HUHenriMondor
• Instagraminstagram.com/hopitauxhenrimondor

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hôpitaux Universitaires Henri-Mondor